StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Whitehawk Therapeutics's ebitda for the twelve months ending Mar 31, 2024 was -$74.44M. For fiscal 2025 it was -$114.32M. The highest annual figure on record is -$2.54M in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$114.32M–
FY2024Dec 31, 2024-$67.27M–
FY2023Dec 31, 2023-$71.76M–
FY2022Dec 31, 2022-$62.52M–
FY2021Dec 31, 2021-$111.11M–
FY2020Dec 31, 2020-$2.54M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$19.46M–
Q4 FY2023Dec 31, 2023-$17.67M–
Q3 FY2023Sep 30, 2023-$17.81M–
Q2 FY2023Jun 30, 2023-$19.50M–
Q1 FY2023Mar 31, 2023-$16.79M–
Q4 FY2022Dec 31, 2022-$15.43M–
Q3 FY2022Sep 30, 2022-$15.02M–
Q2 FY2022Jun 30, 2022-$18.33M–
Q1 FY2022Mar 31, 2022-$13.74M–
Q4 FY2021Dec 31, 2021-$15.87M-288.8%
Q3 FY2021Sep 30, 2021-$87.28M–
Q2 FY2021Jun 30, 2021-$3.87M–
Q1 FY2021Mar 31, 2021-$4.09M–
Q4 FY2020Dec 31, 2020$8.41M–

More Whitehawk Therapeutics figures

See a number that looks wrong?